Jan Storek, MD
Tom Baker Cancer Centre · University of Calgary · Department of Medicine, University of Calgary
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jan Storek, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:56 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03456817 · HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD ProphylaxisAHS Cancer Control Alberta · terminated · Graft-versus-host-disease, Relapse · principal investigator
- Ph2NCT01994824 · Preemptive Therapy of GVHDUniversity of Calgary · terminated · Graft-vs-host Disease · principal investigator
- Ph1/Ph2NCT01339455 · Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis OpticaUniversity of Calgary · terminated · Neuromyelitis Optica · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.